BECTON, DICKINSON AND COMPANY Gain on Sale of Investments
BECTON, DICKINSON AND COMPANY (BDX) reported Gain on Sale of Investments of $0 for the 12-month period ending 2020-09-30, per its 10-K filed 2020-11-25.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:GainOnSaleOfInvestments · last filed 2020-11-25
- BECTON, DICKINSON AND COMPANY gain on sale of investments for the quarter ending 2019-09-30 was $0.00.
- BECTON, DICKINSON AND COMPANY gain on sale of investments for the quarter ending 2019-06-30 was -$335.00M, a 208.77% decline year-over-year.
- BECTON, DICKINSON AND COMPANY gain on sale of investments for the quarter ending 2019-03-31 was $0.00.
- BECTON, DICKINSON AND COMPANY gain on sale of investments for the quarter ending 2018-12-31 was $335.00M.
- BECTON, DICKINSON AND COMPANY gain on sale of investments for fiscal 2020 was $0.00.
- BECTON, DICKINSON AND COMPANY gain on sale of investments for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- BECTON, DICKINSON AND COMPANY gain on sale of investments for fiscal 2018 was $303.00M.
- BECTON, DICKINSON AND COMPANY gain on sale of investments for fiscal 2017 was $0.00.
| Period end | Gain on Sale of Investments 3 month | Gain on Sale of Investments 6 month | Gain on Sale of Investments 9 month | Gain on Sale of Investments 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 10-K · filed 2020-11-25 | |||
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | -$335.00M derived: sum of 2 quarters · filed 2020-11-25 | -$335.00M derived: sum of 3 quarters · filed 2020-11-25 | $0.00 10-K · filed 2020-11-25 |
| 2019-06-30 | -$335.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-06 | -$335.00M derived: sum of 2 quarters · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | -$5.00M derived: sum of 4 quarters · filed 2020-11-25 |
| 2019-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-09 | $335.00M 10-Q · filed 2019-05-09 | $330.00M derived: sum of 3 quarters · filed 2020-11-25 | $638.00M derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-12-31 | $335.00M 10-Q · filed 2019-02-05 | $330.00M derived: sum of 2 quarters · filed 2020-11-25 | $638.00M derived: sum of 3 quarters · filed 2020-11-25 | $638.00M derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-09-30 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | $303.00M derived: sum of 2 quarters · filed 2020-11-25 | $303.00M derived: sum of 3 quarters · filed 2020-11-25 | $303.00M 10-K · filed 2020-11-25 |
| 2018-06-30 | $308.00M 10-Q · filed 2019-08-06 | $308.00M derived: sum of 2 quarters · filed 2019-08-06 | $308.00M 10-Q · filed 2019-08-06 | $308.00M derived: sum of 4 quarters · filed 2019-11-27 |
| 2018-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-09 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 3 quarters · filed 2019-11-27 | |
| 2017-12-31 | $0.00 10-Q · filed 2019-02-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-27 | ||
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $0.00 10-K · filed 2019-11-27 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-02 | |||
| 2016-09-30 | $0.00 10-K · filed 2018-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |